Showing results (241-250 of 481) with videos related to
Sort By:
Pageof 49
Infection and Immunity|March 1, 1984
Activation of human complement by the pneumococcal toxin pneumolysinJ C Paton, B Rowan-Kelly, A FerranteTransactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1983
Polyamine oxidase mediates intra-erythrocytic death of Plasmodium falciparumA Ferrante, C M Rzepczyk, A C AllisonRheumatology International|January 1, 1990
Neutrophil-mediated cartilage injury in vitro is enhanced by tumour necrosis factor alphaI C Kowanko, E J Bates, A FerranteClinical and Experimental Immunology|June 1, 1990
Polyamine oxidase activity in rheumatoid arthritis synovial fluidA Ferrante, R J Storer, L J ClelandImmunology|March 1, 1991
Characterization of the major neutrophil-stimulating activity present in culture medium conditioned by Staphylococcus aureus-stimulated mononuclear leucocytesE J Bates, A Ferrante, L J BeardPediatric Research|April 1, 1987
Effects of neutrophil migration inhibitory factors on neonatal neutrophilsI C Kowanko, A Ferrante, G M MaxwellThe Australian Journal of Experimental Biology and Medical Science|December 1, 1978
A method for the assay of ablastin in the serum of rats infected with Trypanosoma lewisiA Ferrante, P A Drew, C R JenkinImmunology and Cell Biology|October 1, 1989
Mechanisms of human neutrophil-mediated cartilage damage in vitro: the role of lysosomal enzymes, hydrogen peroxide and hypochlorous acidI C Kowanko, E J Bates, A FerranteInternational Archives of Allergy and Applied Immunology|January 1, 1990
Studies of chemotactic, chemotactic movement-inhibiting and random movement-inhibiting effects of interleukin-1 alpha and beta, tumour necrosis factors alpha and beta and interferon gamma on human neutrophils in assays using 'sparse-pore' polycarbonate (Nuclepore) membranes in the Boyden chamberL P Bignold, A Ferrante, D R HaynesInternational Archives of Allergy and Immunology|January 1, 1992
Inhibition of neutrophil respiratory burst and degranulation responses to platelet-activating factor by antagonists WEB 2086, CV 6209 and CV 3988E J Bates, D P Harvey, A FerrantePageof 49